Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
clinicaltrials.gov Identifier: NCT00810147
clinicaltrials.gov Identifier: NCT00810147
h-index: Number of publications with at least h citations each.